A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

Authors:
  • SCShirley G. Cianflone
    Shirley G. Cianflone
  • ADAnn Marie Dose
    Ann Marie Dose
  • PEPaul S. Etzell
    Paul S. Etzell
  • NBNora L. Burnham
    Nora L. Burnham
  • TTTerry M. Therneau
    Terry M. Therneau
  • LHLeRoyce Hagen
    LeRoyce Hagen
  • DGDebra K. Gainey
    Debra K. Gainey
  • MCMadolyn Cross
    Madolyn Cross
  • LALaureen M. Athmann
    Laureen M. Athmann
  • TFTammy Fischer
    Tammy Fischer
  • MOMichael J. O'Connell
    Michael J. O'Connell

Abstract
Pursuant to a promising report suggesting that an allopurinol mouthwash could have a protective effect against 5-fluorouracil (5-FU)-induced stomatitis, the authors performed a randomized, placebo-controlled, double-blind, crossover study. Seventy-seven patients, receiving their first 5-day course of chemotherapy with 5-FU ± leucovorin, were assigned to use a mouthwash containing 20 mg of allopurinol or a placebo. The mouthwash was administered every hour for four doses commencing with each chemotherapy dose. The severity of subsequent mucositis was graded (on a 0-4 scale) by the attending physician and also by a patient-completed questionnaire. There was trend toward less mucositis in the placebo group with mean physician-judged mucositis scores of 1.3 for placebo and 1.8 for allopurinol (P = 0.07) and mean patient-judged mucositis scores of 1.5 for placebo and 1.9 for allopurinol (P = 0.15). There were no substantial differences in mucositis attributable to the two mouthwashes in the patients who crossed-over on their second cycle of chemotherapy. These data demonstrate that the tested allopurinol mouthwash regimen does not offer any protective effect against 5-FU-induced mucositis.